Drawing for ETERNITY HEALTH

USPTO serial 79280388

ETERNITY HEALTH

Reviewed by CopyMark Law Group

Reg. 6263412Status 700Renewal
Filing date
Status date
Registration date
Feb 9, 2021
Examiner
PEISECKI, MARK A
Law office
PUBLICATION AND ISSUE SECTION

What this means

This registration is in, or will soon enter, a USPTO maintenance window. Missing a Section 8 or Section 9 filing can cancel the registration.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with ETERNITY HEALTH?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Get help with this Renewal, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $797*

Plus Government fees of $975

Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Timothy R. DeWitt

Timothy R. DeWitt 24IP Law Group USA, PLLC515 Third StreetAnnapolis, MD 21403UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
035Business organization and operation consultancy; advisory services relating to business management and business operations; market advisory services namely, market research; organizational consultancy and business administration, with and without the aid of electronic databases; business planning services; business management consulting services in the field of information technology; computerized business management services for others; computerized mallet research services; Acquisition and merger consultation, namely, business merger services; business services, namely assisting others in the establishment of businesses; Marketing research services, namely, conducting market research surveys for qualitative market research; business strategy development services; development of hospital management systems; development of marketing strategies and concepts; business development services; business management; business management services relating to the acquisition of businesses; management of health care ethics for others; hospital management, business assistance relating to the formation of commercial undertakings; business project management; human resources management and recruitment services; business risk assessment services; business acquisitions consultation; business advice relating to marketing; business advisory services relating to company performance; business merger consultation; business consultancy services relating to insolvency, business advice relating to marketing management consultations; business advice relating to strategic marketing business advisory; services relating to business liquidations; business advice relating to the sale of businesses; business advice relating to growth financing business consultation and business management regarding launching of new products; business administration; business and market research; business management supervisionACTIVE—
036Facilitating and arranging for the financing of companies and projects in the pharmaceutical, medical device, digital health and healthcare industries; investment consultancy-, equity financing services; financial consultancy in relation to the buying and selling of businesses; financial advisory and financial management services; Facilitating and arranging for the financing of health care; financing in relation to the buying and selling of businesses; financing of business mergers; financing of business acquisitions; financial management of holding companies; fund management, namely, Management of private equity and venture capital funds; investment advisory services; real estate escrow services; arranging finance for businesses, namely, Business finance procurement services; financial managementACTIVE—
042Information technology [IT] consultancy services; computer technology and information technology consultancy services; Computer programing services, namely, information technology programing services; information technology consulting services for the pharmaceutical and healthcare industries; advisory services relating to science, namely, technological advisory services relating to machine engineering analysis; scientific research services and design relating thereto in the field of pharmaceutical, medical device, digital health and healthcare; scientific research services; scientific and technological services, namely, namely scientific research, analysis, and testing in the field of pharmaceutical, medical device, digital health and healthcare industriesACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Feb 9, 2026REM3COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED—
Jun 7, 2021FINOFINAL DECISION TRANSACTION PROCESSED BY IB—
May 12, 2021FICSFINAL DISPOSITION NOTICE SENT TO IB—
May 12, 2021FIMPFINAL DISPOSITION PROCESSED—
May 9, 2021FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
Apr 8, 2021CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED—
Apr 8, 2021TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Apr 8, 2021ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Apr 8, 2021REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Apr 8, 2021COARTEAS CHANGE OF OWNER ADDRESS RECEIVED—
Feb 9, 2021R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Dec 6, 2020GPNXNOTIFICATION PROCESSED BY IB—
Dec 4, 2020NREPNEW REPRESENTATIVE AT IB RECEIVED—
Nov 24, 2020NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Nov 24, 2020PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Nov 18, 2020OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
Nov 18, 2020OP2RNOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB—
Nov 4, 2020NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Oct 31, 2020CHLDCHANGE OF OWNER RECEIVED FROM IB—
Oct 21, 2020CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Sep 29, 2020TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Sep 29, 2020CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Sep 29, 2020TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Apr 18, 2020RFNTREFUSAL PROCESSED BY IB—
Mar 31, 2020RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Mar 31, 2020RFRRREFUSAL PROCESSED BY MPU—
Mar 19, 2020RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Mar 18, 2020CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Mar 16, 2020DOCKASSIGNED TO EXAMINER—
Mar 13, 2020MAFRAPPLICATION FILING RECEIPT MAILED—
Mar 9, 2020NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Mar 5, 2020REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance